News

Essity Reports Strong Performance Amid Economic Challenges

Essity Reports Strong Performance Amid Economic Challenges

Continuous Growth and Resilience in Tough Times

Essity's recent interim report for the second quarter of 2025 showcases the company's ability to navigate through economic headwinds while maintaining a focus on growth and innovation. Even with a challenging economic backdrop, Essity demonstrated a stronger financial performance, indicating a commitment to both its customers and the broader market.

Financial Highlights

In the second quarter of 2025, Essity reported net sales amounting to SEK 34,185 million, reflecting a decline of 6.6% from the previous year. However, when excluding the adverse effects of currency translation, the company actually achieved an increase in sales of SEK 699 million. The organic growth stood at 1.9%, with a notable contribution of 0.2% from volume and 1.7% from price/mix.

EBITA and Profit Metrics

EBITA for the period fell by 12% to SEK 4,628 million, while excluding integration and acquisition costs (IAC), it decreased by 13% to SEK 4,693 million. This decline was partly offset by improved gross margins supported by pricing adjustments aimed at mitigating rising costs. The EBITA margin excluding IAC came in at 13.7%, slightly lower than the 14.7% reported last year, showcasing resilience amid fluctuating market conditions.

CEO's Insights

Ulrika Kolsrud, the newly appointed President and CEO of Essity, spoke about the challenges faced during this quarter. She highlighted the achievement of positive organic sales growth and the company’s earnings of SEK 4.7 billion, thanks to their robust portfolio of essential hygiene and health solutions. Despite a weak economy that limited volume growth, Essity remains focused on serving its consumers effectively.

Challenging Market Dynamics

Particularly in the Consumer Goods sector, incontinence and feminine care products showed strong performance. However, the baby care market presented challenges due to low birth rates and heightened competition. The hospitality sector faced reduced demand, impacting the Professional Hygiene segment, while healthcare experienced some difficulties, particularly in certain markets affecting incontinence products.

Strategic Investments and Future Directions

Essity recognizes the importance of its solutions regardless of the wider economic environment. Significant investments are being made to enhance product offerings across various market segments. Recent upgrades have been implemented in the Consumer Tissue category, particularly with brands like Cushelle Simply Soft and Lotus Comfort, appealing to cost-sensitive consumers.

Growth Initiatives

Essity is committed to executing several growth strategies in profitable categories and attractive markets. There are promising outcomes from initiatives related to JOBST Lymphology, Cutimed Advanced Wound Care, and TENA Men. The company is enthusiastic about harnessing potential growth through focused marketing and customer engagement strategies.

Customer-Centric Focus

Kolsrud emphasized the need for a stronger focus on both customers and consumers since she took over as CEO. Engaging with employees and gathering insights from within the organization have been pivotal. She expressed enthusiasm for enhancing Essity's competitive edge and increasing market shares through effective consumer interactions.

Aiming for Broader Reach

Essity currently touches the lives of around one billion people globally across 150 countries, recognizing that there are still seven billion potential customers. The company remains determined to expand its reach, aiming to improve the quality of life through its health and hygiene products while creating lasting value for shareholders.

Presentation Announcement

To discuss the interim report further, Kolsrud and CFO Fredrik Rystedt will hold a live webcast and teleconference. Interested participants are encouraged to join the call and may reach out in advance for any queries regarding the report.

Frequently Asked Questions

What were Essity's main financial highlights for Q2 2025?

Essity reported net sales of SEK 34,185 million with an organic growth of 1.9% despite a challenging economic climate.

Who is the President and CEO of Essity?

Ulrika Kolsrud is the President and CEO of Essity, having assumed the role in June 2025.

What impact did currency translation have on Essity's sales?

Currency translation effects negatively impacted both net sales and earnings, although the company showed growth when adjusted for these effects.

Which segments showed growth during the second quarter?

Incontinence and feminine care products showed strong growth, while the baby care segment faced challenges.

How is Essity planning to increase its market presence?

Essity aims to accelerate profitable growth through enhanced customer focus, strategic investments, and effective marketing initiatives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 43

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 1

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 0

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 41

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 6

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 59

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
U.S. Millionaire Surge: Market Waves or Mirage?

Updated Category News Views 0

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Continue Reading
Chicago Scenic Studios’ Equipment Up for Grabs in Auction

Updated Category News Views 3

A Peek into the Sale: What's on the Block? Get that coffee brewing and settle in, because we've got to unpack some interesting stuff happening with Chicago Scenic Studios. This isn't just any Craigslist decampment—Integra Asset Solutions is rolling out an online auction come October 27 that’ll have equipment-savvy investors’ ears perking up like they just snagged a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 34

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 2

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Samsung Partners with AI Innovators for Galaxy S26 Launch

Updated Category News Views 234

Samsung’s Ambitious AI Integration for Galaxy S26 Samsung Electronics SSNLF is actively pursuing partnerships with OpenAI and Perplexity AI as it strives to incorporate a wider array of artificial intelligence capabilities into its next-generation Galaxy devices. The company's intent is to diversify its AI services, significantly reducing its previous dependency on...

Continue Reading
Orion Corporation's Recent Share Transactions by Eija Ronkainen

Updated Category News Views 151

Overview of Managers' Transactions at Orion Corporation Orion Corporation is committed to transparency and accountability in its operations. Recently, a disclosure was made concerning share transactions involving Eija Ronkainen, a notable member of the company's Board. This transaction is governed by the Market Abuse Regulation (EU) No 596/2014. Details of the Disclosure...

Continue Reading
Essity Reports Strong Performance Amid Economic Challenges

Updated Category News Views 215

Continuous Growth and Resilience in Tough Times Essity's recent interim report for the second quarter of 2025 showcases the company's ability to navigate through economic headwinds while maintaining a focus on growth and innovation. Even with a challenging economic backdrop, Essity demonstrated a stronger financial performance, indicating a commitment to both its...

Continue Reading
Lantheus Holdings Faces Class Action Lawsuit from Shareholders

Updated Category News Views 132

Lantheus Holdings and the Class Action Lawsuit Lantheus Holdings, Inc. (NASDAQ: LNTH) is currently embroiled in a securities fraud class action lawsuit that has garnered attention from investors. This development comes after a shareholder filed a suit on behalf of those who acquired shares of the company between specific dates in 2025. Details of the Lawsuit The lawsuit...

Continue Reading
Ménage à Trois Introduces New Low-Calorie White Wine

Updated Category News Views 154

Ménage à Trois Introduces Light Sauvignon Blanc Fresh and flavorful, the Light Sauvignon Blanc from Ménage à Trois is set to delight consumers while catering to the growing demand for low-alcohol wines. With only 90 calories and 8% alcohol by volume, this new addition reflects the brand's commitment to providing products that align with modern lifestyles. Expanding...

Continue Reading